Skip to content
MaxCyte Logo
  • Home
  • About Us
    • Leadership
    • Board of Directors
    • Company History
    • Distributors
    • Careers
    • Legal
  • Non-Viral
  • Products
    • Instruments
      • ATxâ„¢
      • GTxâ„¢
      • STxâ„¢
      • VLxâ„¢
    • Consumables
      • RUO Processing Assemblies
      • Processing Assemblies Accessories
      • GMP Processing Assemblies
      • Processing Assemblies Order / Quote Request
  • Resources
    • Applications
      • Cell-Based Assays
      • Gene Editing
      • Primary Cells
      • Protein Production
      • Stem Cells
      • TCR/CAR T
    • Publications
      • Application Notes
      • Posters
      • Primary Literature
      • Product Literature
      • Webinars
      • White Papers
      • Scientific Brief
      • Scientific Presentation
  • Investors
  • Events
    • News
      • MaxCyte® Minutes
      • Twitter feed
      • Virtual 3D booth
      • News Releases
    • Events
      • Upcoming Events
      • Webinars Series
      • On Demand Live Seminars
      • Investor Events
  • Contact Us
Previous Next
  • View Larger Image

Improving NK Cell-based Cancer Immunotherapy via mRNA Electroporation

ali2021-10-12T18:47:30+00:00May 16th, 2020|0 Comments

Share This Story, Choose Your Platform!

FacebookTwitterLinkedInRedditWhatsAppTumblrPinterestVkEmail

Leave A Comment Cancel reply

MaxCyte, Inc.

9713 Key West Avenue
Suite 400
Rockville, MD 20850
Tel: +1-301-944-1700
Fax: +1-301-944-1703

Life Sciences

Consumables

Careers

Legal

Applications

Investors

ExPERT Platform

MaxCyte Minutes

Instruments

About Us

Resources

Distributors

Contact Ustwitter linkedin

© 2022 MaxCyte, Inc. All rights reserved. MaxCyte®, MaxCyte ATx®, MaxCyte GTx®, MaxCyte STx®, MaxCyte VLX®, Flow Transfection®, Flow Electroporation®, Any Cell. Any Molecule. Any Scale.®, CARMA®, ®, ®, ® and ® are trademarks of MaxCyte, Inc., registered in the U.S. Patent and Trademark Office. MaxCyte GTxTM, MaxCyte STxTM, ExPERT ATxTM, ExPERT GTxTM, ExPERT STxTM, ExPERT VLxTM, ExPERTTM, ATxTM, GTxTM, STxTM, VLxTM, TM, TM, MaxCyte CARMATM and CARMA Cell TherapiesTM are trademarks of MaxCyte, Inc.

Go to Top